Neurocrine Biosciences
NBIX
#1374
Rank
NZ$26.70 B
Marketcap
NZ$267.85
Share price
-0.33%
Change (1 day)
21.12%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no stock splits for this company